Prorenoate potassium
| Clinical data | |
|---|---|
| Other names | SC-23992; 6α,7α-Dihydro-17-hydroxy-3-oxo-3'H-cyclopropa(6,7)-17α-pregna-4,6-diene-21-carboxylic acid monopotassium salt | 
| Drug class | Antimineralocorticoid | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H31KO4 | 
| Molar mass | 410.595 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Prorenoate potassium (developmental code name SC-23992) is a synthetic steroidal antimineralocorticoid which was never marketed.